The National Institute of Neurological Disorders and Stroke (NINDS) issued a new Clinical Advisory on September 19, 2011: Secondary Prevention of Small Subcortical Strokes Trial: NINDS Stops Treatment with Combination Antiplatelet Therapy (Clopidogrel plus Aspirin) Due to Higher Risk of Major Hemorrhage and Death (http://www.nlm.nih.gov/databases/alerts/2011_ninds_stroke.html) NINDS has stopped the combination antiplatelet intervention in the Secondary … Continue reading Clinical Advisory from NINDS